Mindfulness Program for Children with Juvenile Arthritis
(M3-JIA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The investigator will evaluate the efficacy of M3©, an intervention for patients with JIA and their caregivers. Children with Juvenile arthritis and their parents will attend an 8 week online program called Making Mindfulness Matter (M3). This is a facilitator-led program that integrates knowledge and skills related to mindfulness, social-emotional learning, neuroscience, and positive psychology to promote coping and resiliency for children and families in context of the challenges of pediatric chronic disease. The child program is designed for children 4-12 years of age, with each lesson including a variety of concrete ways to teach children skills based on their age/developmental level.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that you cannot be enrolled in other intervention trials or practice complementary health interventions like yoga or meditation.
Is the mindfulness program safe for children with juvenile arthritis?
The research on similar interventions like yoga and cognitive-behavioral techniques for children with juvenile arthritis suggests they are generally safe and can help reduce pain and improve mood. These approaches have been well-received by participants and show potential as part of a comprehensive treatment plan.12345
How does the M3 treatment differ from other treatments for juvenile arthritis?
What data supports the effectiveness of the treatment M3 for children with juvenile arthritis?
The research suggests that using coping strategies like problem-solving and positive self-statements can help reduce pain in children with juvenile arthritis. Mindfulness programs, which often include similar techniques, might also be effective in managing pain and improving well-being in these children.35789
Who Is on the Research Team?
Roberta Berard, MD
Principal Investigator
LHSC Children's Hospital/ Lawson Research
Are You a Good Fit for This Trial?
This trial is for children aged 4-12 with Juvenile Idiopathic Arthritis (JIA) and their caregivers. It's designed to help them cope with the challenges of chronic disease through an online program focusing on mindfulness and positive psychology.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week online mindfulness-based intervention program called Making Mindfulness Matter (M3), with weekly sessions for children and parents.
Follow-up
Participants complete follow-up questionnaires to assess the impact of the intervention on various health and psychological outcomes.
Waitlist Control
Control group participants receive the intervention after the initial treatment group, ensuring all participants eventually receive the program.
What Are the Treatments Tested in This Trial?
Interventions
- M3
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lawson Health Research Institute
Lead Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Brain Canada
Collaborator